| Line Item | 2023-08-31 | Y/Y |
|---|---|---|
| R&D Expense | $765K | -29.7% |
| SG&A Expense | $1.5M | -56.3% |
| Operating Income | -$2.3M | +50.1% |
| Pre-tax Income | -$2.4M | +52.4% |
| Net Income | -$2.4M | +51.6% |
| EPS (Basic) | -$0.04 | +55.6% |
| EPS (Diluted) | -$0.04 | +55.6% |
| Line Item | 2023-08-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $493K | -93.9% |
| Short-term Investments | $5.5M | — |
| Current Assets | $6.3M | -24.6% |
| Total Assets | $7.6M | -21.4% |
| Current Liabilities | $287K | +142.6% |
| Total Liabilities | $287K | +142.6% |
| Stockholders' Equity | $7.3M | -23.4% |
| Line Item | 2023-08-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.1M | +42.7% |
| Capital Expenditures | $0 | -100.0% |
| Investing Cash Flow | -$5.5M | -218.5% |
| Free Cash Flow | -$2.1M | +47.9% |